Following the first wave of the pandemic, the Hungarian government launched the Health Industry Support Program helping to implement plans that will strengthen the self-sufficiency of the Hungarian healthcare industry, reduce the country’s vulnerability, and ensure economic growth. Medical investments are the ventures of the future to which Hungary has the expertise and know-how; therefore, today, it can manufacture products that previously had to be imported.
“Our main and most important goal is for Hungary to be self-sufficient in the medical sector and protect our citizens’ health. These investments provide a cheaper and easier solution to purchase the necessary products,” – said Mihály Varga, Hungary’s Financial Minister, about the Health Industry Support Program.
The government supported Masterplast’s 9,5 billion forints worth development with 7,5 billion forints. You can find further information about our investment and the Health Industry Support Program on the government’s website.
Masterplast’s greatest investment was established in Sársentmihály. The plant can manufacture 7000 tons, a wide range of medical protective clothing raw materials. The cutting-edge, fully automated production line manufactures raw materials for customized medical protective gear, clothing, and hygienic products. This healthcare sector-related investment, unique in the entire Carpathian basin, contributes to strengthening Hungary’s pandemic medical defense capability by covering the raw material needs of the local and regional health industry producers from a domestic source.
The new plant opened on 29th June 2021 during a ceremony where Mihály Varga, Hungary’s Minister of Finance, made a speech. In the second half of 2021, production started providing a workplace for 50 new employees at the 7,700-square-meter large new facility.
Later on, Masterplast initiated a new medical investment to establish capacity for medical finished product manufacturing. This expansion concluded in September 2021 is connected to the previous investment in producing medical raw materials as finished product manufacturing also took place here. The acquisition cost 2,6 billion Hungarian forints, to which the Ministry of Finance provided an 80% non-refundable subsidy within the framework of the Health Industry Support Program.
The total value of Masterplast’s investments in medical manufacturing has reached 12 billion Hungarian Forints. By developing the production capacity of finished goods, integrated production is now possible in the company’s healthcare segment, which can cover the whole manufacturing process from raw materials to finished goods. And by doing so, the Hungarian company contributes to increasing the protective measures in Hungary during the pandemic.
The investment that only took six months to complete enables the manufacturing of finished medical goods such as protective coveralls, medical gowns, scrubs, shoe covers, surgical caps, and isolation sheets. With this unit, the company created 40 new jobs and ensures high productivity with a high degree of automation and cutting-edge machinery while maintaining strict hygiene and quality assurance standards of the healthcare industry.
Images about our opening ceremony
